Alexander William Thomas - 15 Nov 2025 Form 4 Insider Report for BED BATH & BEYOND, INC. (BYON)

Role: Chief Operating Officer
Signature: /s/ Christina Wheeler, Attorney-in-Fact
Issuer symbol: BYON
Transactions as of: 15 Nov 2025
Net transactions value: -$2,068
Form type: 4
Filing time: 18 Nov 2025, 16:06:02 UTC
Previous filing: 15 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Thomas Alexander William	Chief Operating Officer	433 ASCENSION WAY, SUITE 300, MURRAY	/s/ Christina Wheeler, Attorney-in-Fact	18 Nov 2025	0002060661

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBBY	Common Stock	Options Exercise	$0.1186	+1,186	+15%	$0.000100	9,136	15 Nov 2025	Direct
transaction	BBBY	Common Stock	Tax liability	$2,068	-343	-3.8%	$6.03	8,793	15 Nov 2025	Direct
holding	BBBY	Common Stock						66	15 Nov 2025	Based on 11/17/25 401k Plan balance provided by Fidelity

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBBY	Restricted Stock Units	Options Exercise	$0	-1,186	-2.7%	$0.000000	43,143	15 Nov 2025	Common Stock	1,186		Direct	F1
transaction	BBBY	Common Stock Warrant	Award	$0	+794		$0.000000	794	07 Oct 2025	Common Stock	794	$15.50	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in two equal installments at the close of business on November 15, 2025 and November 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amount shown does not include previously granted RSUs with different vesting schedules.
F2	Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one common share at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
F3	The warrants will become exercisable beginning as of the date a registration statement on Form S-3 registering the issuance of the shares upon exercise of the of the warrants is declared effective by the SEC and may be exercised at any time thereafter through the Expiration Date.